BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26037138)

  • 21. Proteomic profiling of longitudinal changes in kidney function among middle-aged and older men and women: the KORA S4/F4/FF4 study.
    Lin JS; Nano J; Petrera A; Hauck SM; Zeller T; Koenig W; Müller CL; Peters A; Thorand B
    BMC Med; 2023 Jul; 21(1):245. PubMed ID: 37407978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of renal function before and after percutaneous mitral valve repair.
    Wang A; Sangli C; Lim S; Ailawadi G; Kar S; Herrmann HC; Grayburn P; Foster E; Weissman NJ; Glower D; Feldman T
    Circ Cardiovasc Interv; 2015 Jan; 8(1):. PubMed ID: 25593120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study.
    Lamprea-Montealegre JA; Sharrett AR; Matsushita K; Selvin E; Szklo M; Astor BC
    Atherosclerosis; 2014 May; 234(1):42-6. PubMed ID: 24607852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation.
    Navaravong L; Barakat M; Burgon N; Mahnkopf C; Koopmann M; Ranjan R; Kholmovski E; Marrouche N; Akoum N
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):21-7. PubMed ID: 25142836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymatic creatinine assays allow estimation of glomerular filtration rate in stages 1 and 2 chronic kidney disease using CKD-EPI equation.
    Kuster N; Cristol JP; Cavalier E; Bargnoux AS; Halimi JM; Froissart M; Piéroni L; Delanaye P;
    Clin Chim Acta; 2014 Jan; 428():89-95. PubMed ID: 24220551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A population-based approach for the definition of chronic kidney disease: the CKD Prognosis Consortium.
    Cirillo M; Lombardi C; Mele AA; Marcarelli F; Bilancio G
    J Nephrol; 2012; 25(1):7-12. PubMed ID: 22038337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between thyroid dysfunction and chronic kidney disease in community-dwelling older adults.
    Gopinath B; Harris DC; Wall JR; Kifley A; Mitchell P
    Maturitas; 2013 Jun; 75(2):159-64. PubMed ID: 23541904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung Health Study.
    Zhang Y; Chang Y; Ryu S; Cho J; Lee WY; Rhee EJ; Kwon MJ; Pastor-Barriuso R; Rampal S; Han WK; Shin H; Guallar E
    Int J Epidemiol; 2014 Oct; 43(5):1624-32. PubMed ID: 25011453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic kidney disease in patients with ischemic stroke.
    Tsukamoto Y; Takahashi W; Takizawa S; Kawada S; Takagi S
    J Stroke Cerebrovasc Dis; 2012 Oct; 21(7):547-50. PubMed ID: 21295995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A genome-wide association meta-analysis on apolipoprotein A-IV concentrations.
    Lamina C; Friedel S; Coassin S; Rueedi R; Yousri NA; Seppälä I; Gieger C; Schönherr S; Forer L; Erhart G; Kollerits B; Marques-Vidal P; Ried J; Waeber G; Bergmann S; Dähnhardt D; Stöckl A; Kiechl S; Raitakari OT; Kähönen M; Willeit J; Kedenko L; Paulweber B; Peters A; Meitinger T; Strauch K; ; Lehtimäki T; Hunt SC; Vollenweider P; Kronenberg F
    Hum Mol Genet; 2016 Aug; 25(16):3635-3646. PubMed ID: 27412012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
    Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.
    Peters KE; Davis WA; Ito J; Winfield K; Stoll T; Bringans SD; Lipscombe RJ; Davis TME
    Diabetes Care; 2017 Nov; 40(11):1548-1555. PubMed ID: 28851702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between the fatty liver index and chronic kidney disease: the population-based KORA study.
    Cai X; Thorand B; Hohenester S; Koenig W; Rathmann W; Peters A; Nano J
    Nephrol Dial Transplant; 2023 May; 38(5):1240-1248. PubMed ID: 36150717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity and its relation to chronic kidney disease: a population-based, cross-sectional study of a Thai army population and relatives.
    Satirapoj B; Supasyndh O; Mayteedol N; Punpanich D; Chaiprasert A; Nata N; Ruangkanchanasetr P; Kanjanakul I; Choovichian P
    Nephrology (Carlton); 2013 Mar; 18(3):229-34. PubMed ID: 23279639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A better diet quality is associated with a reduced likelihood of CKD in older adults.
    Gopinath B; Harris DC; Flood VM; Burlutsky G; Mitchell P
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):937-43. PubMed ID: 22902186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endostatin level is associated with kidney injury in the elderly: findings from two community-based cohorts.
    Ruge T; Carlsson AC; Larsson TE; Carrero JJ; Larsson A; Lind L; Ärnlöv J
    Am J Nephrol; 2014; 40(5):417-24. PubMed ID: 25401956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low serum bilirubin concentration is a predictor of chronic kidney disease.
    Tanaka M; Fukui M; Okada H; Senmaru T; Asano M; Akabame S; Yamazaki M; Tomiyasu K; Oda Y; Hasegawa G; Toda H; Nakamura N
    Atherosclerosis; 2014 Jun; 234(2):421-5. PubMed ID: 24763407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-density lipoprotein cholesterol, apolipoprotein E and atherogenic index of plasma are associated with risk of chronic kidney disease.
    Smajić J; Hasić S; Rašić S
    Med Glas (Zenica); 2018 Aug; 15(2):115-121. PubMed ID: 30047539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower serum calcium levels are a risk factor for a decrease in eGFR in a general non-chronic kidney disease population.
    Mizushiri S; Daimon M; Murakami H; Kamba A; Osonoi S; Yamaichi M; Matsumura K; Tanabe J; Matsuhashi Y; Yanagimachi M; Tokuda I; Kurauchi S; Sawada K
    Sci Rep; 2018 Sep; 8(1):14213. PubMed ID: 30242201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoproteins A and B and PCSK9: Nontraditional Cardiovascular Risk Factors in Chronic Kidney Disease and in End-Stage Renal Disease.
    Vlad CE; Foia L; Popescu R; Ivanov I; Luca MC; Delianu C; Toma V; Statescu C; Rezus C; Florea L
    J Diabetes Res; 2019; 2019():6906278. PubMed ID: 31915710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.